Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026.
- Largest single sale: $1.6M (25,519 shares) of Bristol Myers Squibb on Apr 1, 2026. Filing
- Last sale before this period: Sep 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | EVP, Chief Financial Officer | Nov 27, 2019 | Apr 2, 2026 |
| Tapestry, Inc. (TPR) | Director | Mar 1, 2024 | Nov 14, 2025 |
| Becton Dickinson (BDX) | Former Executive VP and CFO | Dec 11, 2008 | Nov 13, 2012 |
Also a director at
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 1, 2026, Bristol Myers Squibb: sold 30,000 shares for $1.9M, under a disclosed plan. 1 filing: 1
- Mar 10, 2026, Bristol Myers Squibb: 62,982 shares vested; 24,999 shares in other transactions; 16,114 shares withheld by the company for taxes. 1 filing: 1
- Nov 13, 2025, Tapestry, Inc.: 1,985 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.